| Sign In to gain access to subscriptions and/or personal tools. |
Economic Impact of Transluminal AngioplastyFrom the Department of Radiology, Presbyterian University of Pennsylvania Medical Center, Philadelphia, Pennsylvania
From Health Economics Research, Inc., Chestnut Hill, Massachusetts
From the Department of Surgery, Hospital of University of Pennsylvania, Philadelphia, Pennsylvania
From the Department of Radiology, Hospital of University of Pennsylvania, Philadelphia, Pennsylvania
From the Department of Surgery, Hospital of University of Pennsylvania, Philadelphia, Pennsylvania Using actual bills and follow-up records we attempted to determine the eco nomic impact of percutaneous transluminal angioplasty. The patients selected included forty angioplasties performed early in our experience as well as forty comparable patients who had operations in the same period of time. Clinical follow-up was obtained over four years. The statistics obtained demonstrate the hospital bills for angioplasty were only 24% that of surgical treatment for femo ral lesions ($1,329.00 versus $6,112.00) and 16% for iliac lesions ($1,353.00 versus $7,732.00). Using this patient sample and readily available statistical data, we calculated direct national savings for using angioplasty on all patients suitable and used a standard value of life analysis to estimate the value of lives saved by doing the less dangerous procedure. The sum total savings in the United States from using angioplasty in all suitable candidates as opposed to surgery would be $180 million per year for femoral lesions and $117 million for iliac lesions. This could produce a significant savings in medical costs over the coming years.
Angiology, Vol. 36, No. 11,
772-777 (1985) This article has been cited by other articles:
|
|||||||||||||||||||||||||||
 |
|
|
 |
Sign In to gain access to subscriptions and/or personal tools.
